Clinical Trials Browser

Interventional × Hematologic Neoplasms × afuresertib × Clear all

NCT01531894 2019-07-09

Continuation Study of the Oral AKT Inhibitor GSK2110183

Phase 2 Completed

11 enrolled 8 charts

Other hematologic neoplasm

Neoplasms, Hematologic Neoplasms